目的:研究阻断NF-kB信号通路对人肝门部胆管癌细胞QBC939生长增殖的影响。方法:常规培养QBC939细胞,采用PDTC(100μmol/L)阻断NF-kB信号通路,Westernblot检测核内P65蛋白水平的表达,CCK-8检测细胞生长增殖抑制率,流式细胞仪观察细胞周期与凋亡的变化情况。结果:经PDTC阻断NF-kB信号通路后,与对照组相比,细胞核内P65蛋白水平明显下降(P〈0.05)。CCK-8检测显示细胞增殖活性明显受到抑制,并随时间的延长而愈渐明显,12、24、36h后细胞增殖抑制率分别为(22.53±0.03)%、(46.54±0.03)%、(58.02±0.03)%,与对照组相比差异有统计学意义(P〈0.05)。流式细胞仪检测发现实验组G0/G1期细胞比例高于对照组,分别为(68.53±1.72)%、(38.03±1.35)%,差异有统计学意义(P〈0.05);细胞凋亡率在实验组为(27.68±2.77)%,对照组仅为(9.27±2.36)%,差异有统计学意义(P〈O.05)。结论:阻断NF-kB信号通路诱导人肝门部胆管癌细胞GdG,期阻滞及细胞凋亡,从而抑制细胞生长与增殖,提示NF-kB信号通路组成性激活参与人肝门部胆管癌的发生发展,以NF-kB信号通路作为治疗的靶点可能给人肝门部胆管癌带来新的治疗选择:
Objective: To evaluate the effect of NF-kB pathway interference on the proliferation of QBC939 cells. Methods: Hu- man hilar cholangiocarcinoma QBC939 cells were cultured in RPMI1640 medium, and NF-kB activity was suppressed by PDTC ( 100 μmol/L ). The P65 subunits of NF-kB in the nuclei of QBC939 cells were detected by Western blot analysis. The inhibition rates of cell growth were assayed by the CCK-8 method. Cell cycles and cell apoptosis were analyzed by flow cytometry (FCM). Results: The p65 subunits of NF-kB decreased significantly after PDTC ( 100 μmol/L ) treatment ( P 〈 0.05 ). The CCK-8 assay showed that the prolifer- ation of QBC939 cells was significantly suppressed by PDTC in a time-dependent manner ( P 〈 0.05 ).The inhibition rates were 22.53%±0.03%, 46.54%±0.03%, and 58.02%±0.03% after 12, 24, and 36 h, respectively. Cell cycle analysis by FCM showed that the percentage of QBC939 cells in the G0/G1 phase was increased by PDTC treatment, i.e., 68.53%±1.72% vs. 38.3%±1.35% ( P 〈 0.05 ). PDTC induced 27.68% ±2.77% apoptosis compared with 9.27%±2.36% in the controls ( P 〈 0.05 ). Conclusion: NF-kB func- tions in the cell proliferation and survival of human hilar cholangiocarcinoma QBC939 cells. The inhibition of NF-kB activity induces cell apoptosis and cell cycle arrest in the G0/G1 phase. Thus, targeting the NF-kB signaling pathway can be a new therapeutic strategy for human hilar cholangiocarcinoma.